« Previous Entries

Prostate Cancer – Immunotherapy Works Where Other Treatments Fail

Tuesday, June 5th, 2018

Can immunotherapy work for those prostate cancer patients who didn’t benefit from other treatments? This is the question which researchers investigated in a new study. They have concluded the answer is ‘yes’. According to them, pembrolizumab, an immunotherapy drug, is a viable option to treat prostate cancer that is in advanced stage and has not […]

Soy Intake Linked to Increased Risk of Advanced Prostate Cancer

Thursday, November 9th, 2017

Soy is believed to offer many health benefits, but they are not healthy for men. According to a new study, men who eat soy, as well as other foods with high amounts of isoflavones, have a greater risk of developing advanced prostate cancer, that is, prostate cancer that has developed to other parts of the […]

Italian-Styled Coffee Linked to Lower Prostate Cancer Risk

Monday, April 24th, 2017

If you enjoy a few cups of joe everyday, there’s some good news for you. According to a new study, the risk of prostate cancer can reduce by more than 50 percent if you drink three or more cups of Italian-style coffee daily. This finding came after researchers examined the risk of prostate cancer in […]

Testosterone Therapy does not Increase the Risk of Prostate Cancer

Monday, May 9th, 2016

According to a recent study, men undergoing testosterone replacement therapy (TRP for short) do not have an increased risk of prostate cancer. If anything, the risk of prostate cancer in these men was found to be 50 percent lower than in men who had not been prescribed TRT. This study was done by New York […]

Hormone Therapy Increases Risk of Depression in Prostate Cancer Patients

Wednesday, April 13th, 2016

Men with prostate cancer who undergo androgen deprivation therapy for treating localized prostate cancer have a high risk of suffering from depression, according to a new study published in the Journal of Clinical Oncology. Researchers found that men who are undergoing hormone therapy usually experience lower than normal sexual function, have less energy, and gain […]

Lifespan of Prostate Cancer Survivors Depends On The Site Disease Spreads To

Thursday, March 3rd, 2016

The life span of prostate cancer survivors might be influenced by the body area where the cancer has metastasized or spread to. This is the conclusion made by a recent research. In the US, prostate cancer ranks as the 2 nd most common cancer, the first being the skin cancer. The prognosis of prostate cancer […]

Broccoli Linked With Reduced Risk of Liver Cancer

Monday, February 29th, 2016

Broccoli is good for health in more ways than one. Earlier studies had stated that it helps in prevention of breast, colon, and prostate cancer. Latest research says it also offers protection against liver cancer. Modern diet, which is rich in added sugars as well as high saturated fats, increases the risk of non-alcoholic fatty […]

Radiation Treatment For Prostate Cancer Might Increase Risk of Certain Secondary Cancers

Sunday, February 28th, 2016

Radiation therapy for prostate cancer may increase the risk of other cancers in men, according to a new review. In this review, researchers studied the data of 21 studies involving patients who had undergone radiation treatment. The researchers found that these men showed an increased risk of rectal, colon, and bladder cancers than men who […]

Smoking increases risk of prostate cancer recurrence

Tuesday, January 27th, 2015

According to a new study, prostate cancer patients who had a smoking habit also had an increased risk of cancer recurrence and spreading. Also, past and current smokers had more radiotherapy side effects. The study was led by Michael J. Zelefsky, MD, of the Memorial Sloan Kettering Cancer Center in New York City, who said, […]

Bisphosphonates not always prescribed to prostate cancer patients undergoing ADT

Thursday, December 4th, 2014

A recent study has found prostate cancer patients undergoing androgen deprivation therapy (ADT) are not always prescribed bisphosphonates to strengthen their bones. ADT is known to weaken the bones of prostate cancer patients. The study, led by Shabbir M.H. Alibhai, MD, of the University Heath Network in Toronto, Canada, found that although bisphosphonates are common, […]

« Previous Entries